Talis Biomedical: Jeryl Hilleman

Point-of-care infectious disease firm Talis Biomedical has appointed Jeryl Hilleman to its board of directors, where she will serve as the chair of the audit committee. Currently, she serves as chairman of the board of Omada Health and is a director of Novocure, SI-Bone, and Minerva Neurosciences. Previously, Hilleman was CFO at multiple publicly traded companies, including Intersect ENT, Ocera Therapeutics, Amyris, Symyx Technologies, and Cytel.